miR148b is a major coordinator of breast cancer progression in a relapse‐associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1

D Cimino, C De Pittà, F Orso, M Zampini… - The FASEB …, 2013 - Wiley Online Library
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of
microRNAs (miRs) during malignancy, we analyzed miR expression in 77 primary breast …

[引用][C] miR148b is a major coordinator of breast cancer progression in a relapse‐associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and …

D Cimino, C De Pittà, F Orso, M Zampini, S Casara… - The FASEB …, 2012 - sonar.ch
miR148b is a major coordinator of breast cancer progression in a relapse‐associated microRNA
signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1 SONAR logo Log in Sign up …

miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.

D Cimino, C De Pittà, F Orso, M Zampini… - … : Official Publication of …, 2012 - europepmc.org
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of
microRNAs (miRs) during malignancy, we analyzed miR expression in 77 primary breast …

[PDF][PDF] miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and …

D Cimino, C De Pitta, F Orso, M Zampini, S Casara… - researchgate.net
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of
microRNAs (miRs) during malignancy, we analyzed miR expression in 77 primary breast …

miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1

D Cimino, C De Pittà, F Orso… - … publication of the …, 2013 - pubmed.ncbi.nlm.nih.gov
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of
microRNAs (miRs) during malignancy, we analyzed miR expression in 77 primary breast …

[PDF][PDF] miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and …

D Cimino, C De Pitta, F Orso, M Zampini, S Casara… - publicationslist.org
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of
microRNAs (miRs) during malignancy, we analyzed miR expression in 77 primary breast …

[PDF][PDF] miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and …

D Cimino, C De Pitta, F Orso, M Zampini, S Casara… - academia.edu
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of
microRNAs (miRs) during malignancy, we analyzed miR expression in 77 primary breast …

miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.

D Cimino, C De Pittà, F Orso, M Zampini… - FASEB …, 2013 - search.ebscohost.com
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of
microRNAs (miRs) during malignancy, we analyzed mi expression in 77 primary breast …

miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS and CSF1

D Cimino, C De Pittà, F Orso, M Zampini… - THE FASEB …, 2013 - iris.unito.it
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of
microRNAs (miRs) during malignancy, we analyzed miR expression in 77 primary breast …

miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1

D Cimino, C De Pittà, F Orso, M Zampini… - FASEB …, 2013 - research.uniupo.it
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of
microRNAs (miRs) during malignancy, we analyzed miR expression in 77 primary breast …